GW3965 hydrochloride No Further a Mystery
Other clinical trials in patients with non-Hodgkin's lymphoma [24] and individuals with Sophisticated malignancy [14] have shown also that zosuquidar didn't noticeably impact the pharmacokinetics of doxorubicin and experienced moderate consequences to the pharmacokinetics of vincristine. These medical trials accredited that zosuquidar could safely